Literature DB >> 11064370

Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats.

H Heuer1, M K Schäfer, D O'Donnell, P Walker, K Bauer.   

Abstract

The distribution of the recently discovered thyrotropin-releasing hormone (TRH) receptor subtype TRH-R2 was studied in rat brain, pituitary, and spinal cord by in situ hybridization histochemistry and compared with the distribution patterns of the other elements of TRH signaling, namely TRH, TRH-R1, and the TRH-degrading ectoenzyme (TRH-DE). In contrast to the very restricted mRNA expression of TRH-R1 in the central nervous system, TRH-R2 mRNA was widely distributed with highest transcript levels throughout the thalamus, in the cerebral and cerebellar cortex, medial habenulae, medial geniculate nucleus, pontine nuclei, and throughout the reticular formation. In accordance with the well-known endocrine function of TRH, TRH-R1 is found predominantly expressed in hypothalamic regions. Expression of TRH-R1 in various brainstem nuclei and spinal cord motoneurons seems to be associated with the described effects of TRH on the vegetative and autonomic system as well as on the somatomotor system. Furthermore, the fully complementary expression of both receptor subtypes, even in regions where transcripts for both receptors were found (e.g., medial septum, lateral hypothalamus superior colliculi, substantia nigra, etc.), indicates that in discrete neuroanatomical pathways the two receptors serve highly specific functions for the transmission of TRH signals. Together with TRH-DE, the putative terminator of TRH actions that shows in various, but not all, brain areas, an overlapping mRNA distribution pattern with both receptors, the distribution of TRH-R2 mRNA seems to provide the anatomical basis for the described effects of TRH on higher cognitive functions as well as its effect on arousal, locomotor activity, and pain perception. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064370

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  40 in total

Review 1.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Potent hyperglycemic and hyperinsulinemic effects of thyrotropin-releasing hormone microinjected into the rostroventrolateral medulla and abnormal responses in type 2 diabetic rats.

Authors:  Y Ao; M Ko; A Chen; J C Marvizon; D Adelson; M K Song; V L W Go; Y Y Liu; H Yang
Journal:  Neuroscience       Date:  2010-05-08       Impact factor: 3.590

Review 3.  Brainstem neuropeptides and vagal protection of the gastric mucosal against injury: role of prostaglandins, nitric oxide and calcitonin-gene related peptide in capsaicin afferents.

Authors:  Y Tache
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

4.  The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.

Authors:  M Tanabe; Y Tokuda; K Takasu; K Ono; M Honda; H Ono
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

Review 5.  Role of brainstem TRH/TRH-R1 receptors in the vagal gastric cholinergic response to various stimuli including sham-feeding.

Authors:  Y Taché; H Yang; M Miampamba; V Martinez; P Q Yuan
Journal:  Auton Neurosci       Date:  2006-03-06       Impact factor: 3.145

6.  Distribution and axonal projections of neurons coexpressing thyrotropin-releasing hormone and urocortin 3 in the rat brain.

Authors:  Gábor Wittmann; Tamás Füzesi; Zsolt Liposits; Ronald M Lechan; Csaba Fekete
Journal:  J Comp Neurol       Date:  2009-12-20       Impact factor: 3.215

7.  Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue.

Authors:  John P Dougherty; Brian S Wolff; Mary J Cullen; Leorey N Saligan; Marvin C Gershengorn
Journal:  Pharmacol Res       Date:  2017-07-15       Impact factor: 7.658

8.  Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.

Authors:  Edith Sánchez; Miguel Angel Vargas; Praful S Singru; Isel Pascual; Fidelia Romero; Csaba Fekete; Jean-Louis Charli; Ronald M Lechan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 9.  Anatomy of the hypophysiotropic somatostatinergic and growth hormone-releasing hormone system minireview.

Authors:  Mariann Fodor; Claude Kordon; Jacques Epelbaum
Journal:  Neurochem Res       Date:  2006-04-04       Impact factor: 3.996

10.  Stage-specific modulation of neprilysin and aminopeptidase N in the limbic system during kindling progression.

Authors:  Patricia de Gortari; Miguel Angel Vargas; Adrián Martínez; Arlene I García-Vázquez; Rosa María Uribe; Lucía Chávez-Gutiérrez; Víctor Magdaleno; Guy Boileau; Jean-Louis Charlí; Patricia Joseph-Bravo
Journal:  J Mol Neurosci       Date:  2007-04-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.